The ORBITA sham-control PCI study, Watchman, revascularization in cardiogenic shock, Absorb BVS, quality-of-life outcomes after PCI or bypass, and chronic total occlusion PCI are discussed in this week's podcast.

Eric Topol talks with cardiologist and Verily CMO Jessica Mega about her switch from academic medicine to Silicon Valley, and how Google hopes to transform medicine.

Statins tied to diabetes risk and reduced bacterial infections, a novel use for hs-troponin, mitral-regurgitation management, and His-bundle pacing are reviewed in this week's podcast.

Secondary AF, Heart failure statistics, DOAC bleeding rates, uncontrolled hypertension and stroke risk factors are discussed by John Mandrola in this week's podcast.

Drs Egbe and Said join Dr Melissa Lyle to discuss the progress and challenges in managing patients who have undergone Fontan palliation.

Noninvasive tests for chest pain evaluation, the obesity epidemic, the costs of cardiac device recalls, and DOAC-drug interactions are reviewed in this week's podcast.

CASTLE-AF and AATAC show that ablation for coexisting AF reduces mortality patients with heart failure. 'Sinus rhythm matters,' says Dr Di Biase.

The PURE study suggests that dietary saturated fat is good and carbohydrates bad, but nutritional guidelines should be based purely on randomized data, argues Dr O'Donoghue.

Drs Gayatri Acharya, Michael Ackerman, and Peter Noseworthy discuss the importance of investigating sudden deaths in light of new research showing that many presumed sudden cardiac deaths are not cardiac in origin.

Stopping aspirin, TAVR durability, meditation, triathlon risk, and BP control in low-income patients are discussed by Dr Mandrola in this week's podcast.